Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Bermekimab Monoclonal Antibody 400 mg
DRUG
2 trials
Sponsors
Janssen Research & Development, LLC
Conditions
Atopic Dermatitis
Hidradenitis Suppurativa
Phase 2
A Phase II Study of Bermekimab (MABp1) in Patients With Moderate to Severe Atopic Dermatitis
Completed
NCT03496974
Janssen Research & Development, LLC
Atopic Dermatitis
Start: 2018-05-21
End: 2018-12-11
Updated: 2021-03-12
A Study of Bermekimab in Patients With Hidradenitis Suppurativa
Completed
NCT03512275
Janssen Research & Development, LLC
Hidradenitis Suppurativa
Start: 2018-06-20
End: 2019-01-14
Updated: 2022-03-14
Related Papers
Interleukin-1α inhibitor bermekimab in patients with atopic dermatitis: randomized and nonrandomized studies.
2024-08-30
8 citations